Searched for
PANACEA ACQUISITION
Mankind: How Meerut brothers built India's 4th largest pharma firmMankind Pharma has announced a significant move by acquiring Bharat Serums and Vaccines Ltd for Rs 13,630 crore. The acquisition, partly fu...- Mankind can clear debt taken for BSV buy in 3 years: MD Rajeev JunejaMankind Pharma aims to clear its ₹13,630-crore debt from acquiring Bharat Serums and Vaccines within three years, according to MD Rajeev Ju...
- Market not much enthused by Mankind's BSV buyAfter initially cheering the deal, the stock market gave its thumbs-down to Mankind acquiring BSV at the premium valuations of eight times ...
- Mankind trumps EQT-ADIA to buy BSV for $1.67 bnThis is the largest acquisition by Mankind Pharma, India’s 4th largest pharma company by market share. A formal announcement regarding the ...
- Mankind Pharma scouts for M&A deals to boost local branded bizMankind Pharma, the fourth-largest pharmaceutical company in India, led by Rajeev Juneja, is seeking mergers, acquisitions, and in-licensin...
- JB Pharma open to more buys to grow branded biz shareJB Chemicals & Pharmaceuticals (JB Pharma), controlled by US private equity firm KKR, is evaluating assets for acquisitions to strengthen i...
- Mankind Pharma looking for selective acquisition opportunities: Rajiv JunejaMankind Pharma, a domestic-focused Indian pharmaceutical company is looking for selective acquisition opportunities that add value to its p...
- Why Mankind has an edge over its peers? Rajeev Juneja explainsIn 95, our turnover was Rs 5 crore and every year, the thought was, whatever we are doing in one year, can we do in one month? On this phil...
- Panacea Biotec hits 5% upper circuit after Mankind Pharma dealAs part of this arrangement, Mankind Pharma is retaining Panacea's sales and marketing team engaged in the particular business.
- Mankind Pharma to acquire Panacea's formulation brands for India, NepalBoth the entities have entered into definitive agreements for the transaction involving a total consideration of Rs 1,872 crore. Panacea Bi...
- Stocks in the news: Angel Broking, RIL, Tata steel, CAMS, BEML and YES BankThe government’s proposal to pick up the tab for the waiver of 'interest on interest' on loans of up to Rs 2 crore clears the uncertainty o...
- Narayana Hruduyalaya eyeing Panacea Biotec's Gurgaon HospitalThe 224 bed Gurgaon Hospital has been set up through Panacea Biotec's subsidiary NewRise Healthcare Private Limited in which the company ho...
- Government comes under scathing criticism from RSS-affiliated unionBJP government has come under attack from RSS affiliated workers' body which charged it with being on "wrong track" on the economic and lab...
- Stocks to watch: Uttam Galva, Tata Steel, Bayer Cropscience, Piramal Healthcare...The world's largest steel maker ArcelorMittal is understood to be jointly working with its domestic partner Uttam Galva for setting up a Rs...
- Cyrus Poonawalla acquires 1.53% more in Orchid ChemicalsHigh net worth individual (HNI) and race-horse enthusiast Cyrus Poonawalla has raised his equity stake marginally in Chennai-based drugmake...
- Stocks to Watch: ICICI Bank, Dish TV, Panacea BiotechThe relief rally on Dalal Street may resume Wednesday as the global markets were back in action after an unexpected rebound in homebuilding...
- Panacea to buy 19.9% in PharmAthene for $13.1 mnVaccine maker Panacea Biotec has agreed to buy 19.9% in US-based PharmAthene for $13.1 mn.
- Panacea bags $35-m deal from UnicefPanacea Biotec is learnt to have bagged a $35-million drug supply order from UNICEF to supply pentavalent vaccines, the first Indian compan...
- Top 10 pharma cos post 57% increase in Q3 netBuoyed by overseas acquisitions, the Indian pharma sector has posted a good set of numbers for the third quarter ended December 31, 2006.
- Biozeen to set up consulting facility in PennsylvaniaBangalore-based biopharma company Biozeen, a division of Bangalore Biotech Labs, has announced plans to set up its consulting services in P...
Load More
